Do you guys realise how many times Leslie has been "rosy" about things IMU only for the reality to be something different?
How many "adequately capitalised / long runway" comments have been made just prior to a capital raise?
How many "outstanding clinical results" comments have been made about products in which IMU no longer invests and no longer advances?
How (brilliant for the patient but) irrelevant the timeframe a single patient survives when it comes to proving sufficient statistical benefit to progress to registrational trials of a product (either directly or by licensing to BP)?
How pitiful it is for Leslie to now be touting "outstanding pre-clinical results" when the company was almost the end of a Phase II trial three years ago?
If you base the prospects of a company on its CEO comments, every company would be multi-billion, yet Leslie's comments are all that you're using to suggest IMU is undervalued.
Media Thread, page-12090
-
- There are more pages in this discussion • 2,298 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1921794 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 1368288 | 7 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |